Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues

This article explores regulatory issues regarding the use of biomarkers and surrogate end points in clinical trials of multiple sclerosis with particular emphasis on challenges faced by evoked potential studies.
Source: Journal of Clinical Neurophysiology - Category: Neurology Tags: Invited Review Source Type: research